Medicines and Related Substances Act: Regulations: Transparent pricing system for medicines and scheduled substances: Annual adjustment of single exit price of medicines and scheduled substances for 2018

25th May 2017

In terms of Regulation 8 (1) of the Regulations Relating to the Transparent Pricing System for Medicines and Scheduled Substances of the Medicines and Related Substances Act,1965 (No.101 of 1965) as amended, the Minister of Health is required to determine on an annual basis, the extent to which medicine prices may be adjusted. In making this determination the Minister considers the following provisions of Regulation 8 (1)-